Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 1:01 pm Sale |
2025-03-19 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 2,733,547 4.800% |
-5,784,292 (-67.91%) |
Filing History |
| 2025-03-10 11:12 am Sale |
2025-03-04 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 9,694,064 4.900% |
-250,000 (-2.51%) |
Filing History |
| 2025-02-14 2:39 pm Unchanged |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 9,929,963 15.800% |
0 (Unchanged) |
Filing History |
| 2025-02-14 2:37 pm Purchase |
2024-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB Biotech AG | 9,944,064 5.000% |
750,000 (+8.16%) |
Filing History |
| 2025-02-14 2:36 pm Unchanged |
2024-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB Biotech AG | 8,517,839 15.100% |
0 (Unchanged) |
Filing History |
| 2025-02-14 2:35 pm Sale |
2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
BB Biotech AG | 3,515,150 6.200% |
-484,850 (-12.12%) |
Filing History |
| 2025-01-17 06:02 am Sale |
2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 1,178,503 1.900% |
-3,282,190 (-73.58%) |
Filing History |
| 2024-12-09 6:18 pm Sale |
2024-12-05 | 13G | Generation Bio Co. GBIO |
BB Biotech AG | 3,310,869 5.000% |
-297,411 (-8.24%) |
Filing History |
| 2024-11-18 9:49 pm Sale |
2024-11-14 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 904,001 9.900% |
-125,819 (-12.22%) |
Filing History |
| 2024-11-14 8:34 pm Sale |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB Biotech AG | 7,850,000 5.000% |
-740,000 (-8.61%) |
Filing History |
| 2024-11-14 7:32 pm Sale |
2024-11-01 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 0 0.000% |
-7,879,583 (Position Closed) |
Filing History |
| 2024-11-14 7:21 pm Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BB Biotech AG | 5,157,290 4.900% |
475,000 (+10.14%) |
Filing History |
| 2024-11-14 6:14 pm Purchase |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 4,460,693 7.300% |
955,693 (+27.27%) |
Filing History |
| 2024-04-22 8:35 pm Purchase |
2024-04-17 | 13G | Annexon, Inc. ANNX |
BB Biotech AG | 4,682,290 5.200% |
4,682,290 (New Position) |
Filing History |
| 2024-02-13 11:00 am Purchase |
2023-12-31 | 13G | Molecular Templates, Inc. MTEM |
BB Biotech AG | 1,029,820 19.200% |
1,029,820 (New Position) |
Filing History |
| 2024-02-13 10:13 am Unchanged |
2023-12-31 | 13G | Wave Life Sciences Ltd. WVE |
BB Biotech AG | 4,494,458 3.700% |
0 (Unchanged) |
Filing History |
| 2024-02-13 06:28 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB Biotech AG | 3,505,000 5.800% |
404,722 (+13.05%) |
Filing History |
| 2024-02-13 06:17 am Unchanged |
2023-12-31 | 13G | Generation Bio Co. GBIO |
BB Biotech AG | 3,608,280 5.500% |
0 (Unchanged) |
Filing History |
| 2024-02-13 06:13 am Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 9,929,963 16.000% |
1,000,000 (+11.20%) |
Filing History |
| 2024-02-13 06:09 am Sale |
2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB Biotech AG | 8,590,000 6.000% |
-1,045,000 (-10.85%) |
Filing History |